Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis

Journal of the American Society of Nephrology

Volumn 9, Issue 9, 1998, Pages 1716-1722

  Ferrario, Carlos M ^a   Chappell, Mark C ^a   Dean, Richard H ^a   Iyer, Shridhar N ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ATRIAL NATRIURETIC FACTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; NITRIC OXIDE; PROLYL ENDOPEPTIDASE; PROSTAGLANDIN;

BLOOD PRESSURE REGULATION; DIURESIS; ENDOTHELIUM; HUMAN; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION;

EID: 0031752218     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Burbach JPH: Action of proteolytic enzymes on lipotropins and endorphins: Biosynthesis. Biotransformation and fate. Pharmacol Ther 24: 321-354, 1984
2. Ardaillou R: Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects. Curr Opin Nephrol Hypertens 6: 28-34, 1997
3. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI: Counter-regulatory actions of angiotensin-(1-7). Hypertension 30: 535-541, 1997
4. Bumpus FM, Khosla MC: Angiotensin analogs as determinants of the physiological role of angiotensin and its metabolites. In: Hypertension: Pathophysiology and Treatment, edited by Genest J, Koiw E, Kuchel O, New York, McGraw-Hill, 1977, pp 183-201
5. Ferrario CM, Santos RAS, Brosnihan KB, Block CH, Schiavone MT, Khosla MC, Greene LJ: A hypothesis regarding the function of angiotensin peptides in the brain. Clin Exp Hypertens [A]. 10: 107-121, 1988
6. Santos RAS, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, Ferrario CM: Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 11[Suppl I]: 153-157, 1988
7. Welches WR, Brosnihan KB, Ferrario CM: A comparison of the properties and enzymatic activity of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 52: 1461-1480, 1993
8. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A: Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 66: 883-890, 1990
9. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357, 1990
10. Ferrario CM, Chappell MC: A new myocardial conversion of angiotensin I. Curr Opin Cardiol 9: 520-526, 1994
11. Ahmad A, Ward PE: Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 252: 643-650, 1990
12. Chappell MC, Pirro NT, Sykes A, Ferrario CM: Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31: 362-367, 1998
13. Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM: Converting enzyme determines the plasma clearance of angiotensin-(1-7). Hypertension 1998, in press
14. 1-7 and KetoACE [Abstract]. Hypertension 30: 494, 1997
15. Deddish PA, Marcic B, Jackman HL, Wang H-Z, Skidgel RA, Erdos EG: N-domain specific substrate and C-domain specific inhibitors of angiotensin converting enzyme. Hypertension 31: 912-917, 1998
16. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM: Release of vasopressin from the rat hypothalamoneurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 85: 4095-4098, 1988
17. Baracho NCV, Silva ACS, Khosla MC, Santos RAS: Characterization of the anti-diuretic action of angiotensin-(1-7) in water-loaded rats. Hypertension 25: 1408, 1995
18. Santos RAS, Silva ACS, Magaldi AJ, Khosla MC, Cesar KR, Passaglio KT, Baracho NCV: Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 27: 875-884, 1996
19. Mahon JM, Allen M, Herbert J, Fitzsimons JT: The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II. angiotensin-(1-7) or carbachol. Neurosci Lett 69: 199-208, 1995
20. Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC, Santos RAS: Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol 263: R89-R94, 1992
21. Silva LCS, Fontes MAP, Campagnole-Santos MJ, Khosla MC, Campos RR Jr, Guertzenstein PG, Santos RAS: Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla. Brain Res 613: 321-325, 1993
22. Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB, Ferrario CM: Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol 257: H324-H329, 1989
23. Garcia NH, Garvin JL: Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol 5: 1133-1138, 1994
24. Handa RK, Ferrario CM, Strandhoy JW: Renal actions of angiotensin-(1-7) in vivo and in vitro studies. Am J Physiol 270: F141-F147, 1996
25. Handa RK, Ferrario CM, Strandhoy JW: Angiotensin-(1-7) inhibits oxygen consumption in rat proximal tubules [Abstract]. J Am Soc Nephrol 5: 659, 1994
26. Andreatta-Van Leyen S, Romero MF, Khosla MC, Douglas JG: Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int 44: 932-936, 1993
27. 2 release. Hypertension 25: 1238-1244, 1995
28. DelliPizzi A, Hilchey SD, Bell-Quilley CP: Natriuretic actions of angiotensin-(1-7).Br J Pharmacol 111: 1-3, 1994
29. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension 19[Suppl II]: 49-55, 1992
30. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM: Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: Subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 265: 664-673, 1993
31. Benter IF, Ferrario CM, Morris M, Diz DI: Antihypertensive actions of angiotensin-(I-7) in spontaneously hypertensive rats. Am J Physiol 269: H313-H319, 1995
32. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM: Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension 21: 900-905, 1993
33. Trachte GJ, Ferrario CM, Khosla MC: Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists. J Pharmacol Exp Ther 255: 929-934, 1990
34. Lima CV, Paula RD, Resende FL, Khosla MC, Santos RAS: Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 30: 542-548, 1997
35. Paula RD, Lima CV, Khosla MC, Santos RAS: Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26: 1154-1159, 1995
36. Abbas A, Gorelik G, Carbini LA, Scicli AG: Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension 30: 217-221, 1997
37. Porsti I, Bara AT, Busse R, Hecker M: Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 111: 652-654, 1994
38. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ: Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 234: 35-42, 1993
39. Benter IF, Diz DI, Ferrario CM: Cardiovascular actions of angiotensin-(1-7). Peptides 14: 679-684, 1993
40. Benter IF, Diz DI, Ferrario CM: α-Adrenergic and angiotensin II pressor responses are reduced in angiotensin-(1-7)-treated spontaneously hypertensive rats. Hypertension 25: 1416, 1995
41. Erdos EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16: 363-370, 1990
42. Nasjletti A: The role of eiconsanoids in angiotensin-dependent hypertension. Hypertension 31: 194-200, 1998
43. McGiff JC, Vane JR: Prostaglandins and the regulation of blood pressure. Kidney Int 8: 262-270, 1975
44. 1 angiotensin receptors in spontaneously hypertensive rats. Clin Exp Hypertens 19: 1247-1261, 1997
45. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-141, 1991
46. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997
47. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657, 1995
48. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H: Antihypertensive therapy with MK 421: Angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 4: 966-972, 1982
49. Brunner HR, Gavras H, Turini GA, Waeber B, Chappuis P, McKinstry DN: Long term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor. Clin Sci Mol Med 55: 2934-2959, 1978
50. Carretero OA, Miyazaki S, Scicli AG: Role of kinins in the acute antihypertensive activity of the converting enzyme inhibitor, captopril. Hypertension 3: 18-22, 1981
51. Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Lahera V: Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 26: 236-243, 1995
52. Bao G, Gohlke P, Unger T: Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol 20: S96-S99, 1992
53. Iyer SN, Ferrario CM, Chappell MC: Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the reninangiotensin system. Hypertension 31: 356-361, 1998
54. Ferrario CM, Brosnihan KB, Martell N, Luque M: Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension: Response. J Hypertens 14: 1379-1381, 1996
55. Kohara K, Brosnihan KB, Ferrario CM: Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 14: 883-891, 1993
56. Campbell DJ, Duncan AM, Kladis A, Harrap SB: Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 25: 928-934, 1995
57. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM: Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31: 699-705, 1998
58. Tallant EA, Diz DI, Khosla MC, Ferrario CM: Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension 17: 1135-1143, 1991
59. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM: Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29: 388-392, 1997
60. Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM: Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 14: 799-805, 1996
61. Ferrario CM, Martell N, Yunis C, Flack JM, Chappell MC, Brosnihan KB, Dean RH, Fernandez A, Novikov S, Pinillas C, Luque M: Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens 11: 137-146, 1998
62. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM: Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension 25: 1260-1265, 1995
63. Cowley AW Jr, Mattson DL, Lu SH, Roman RJ: The renal medulla and hypertension. Hypertension 25: 663-673, 1995
64. Admiraal PJ, Derkx FH, Danser AH, Pieterman H, Schalekamp MA: Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15: 44-55, 1990
65. 1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 30: 42-49, 1997
66. Heyne N, Beer W, Muhlbauer B, Osswald H: Renal response to angiotensin (1-7) in anesthetized rats. Kidney Int 47: 975-976, 1995
67. Santos RAS, Baracho NCV: Angiotensin-(1-7) is a potent anti-diuretic peptide in rats. Braz J Med Biol Res 25: 651-654, 1992
68. Tian B, Meng QC, Chen Y-O, Krege JH, Smithies O, Oparil S: Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension 30: 128-133, 1997
69. Silva ACS, Baracho NCV, Khosla MC. Santos RAS: Diuresis and natriuresis produced by long-term administration of a selective angiotensin-(1-7) antagonist in rats. Hypertension 25: 1409, 1995
70. Botelho LMO, Block CH, Khosla MC, Santos RAS: Plasma angiotensin (1-7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage. Peptides 15: 723-729, 1994
71. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides: Characterization of receptors. Hypertension 19: II49-II55, 1992
72. Chappell MC, Diz DI, Ferrario CM: Urinary angiotensin-(1-7): Influence of converting enzyme and neprilysin inhibition. Hypertension 26: 562, 1995
73. Chappell MC, Diz DI, Yunis C, Ferrario CM: Differential actions of angiotensin-(1-7) in the kidney. Kidney Int 1998, in press